The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
MAGENTA THERAPEUTICS, INC. COM 55910K108 29,939 6,758,204 SH   SOLE   6,758,204 0 0
FULCRUM THERAPEUTICS, INC. COM 359616109 41,450 2,343,154 SH   SOLE   2,343,154 0 0
REVOLUTION MEDICINES, INC. COM 76155X100 35,739 1,419,900 SH   SOLE   1,419,900 0 0
PLIANT THERAPEUTICS, INC. COM 729139105 28,794 2,132,867 SH   SOLE   2,132,867 0 0
TANGO THERAPEUTICS, INC. COM 87583X109 211,842 19,363,975 SH   SOLE   19,363,975 0 0